ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The South Korean conglomerate SK Holdings will acquire Ampac Fine Chemicals as part of its plan to become a top-tier pharmaceutical contract development and manufacturing firm. Owned by the private equity firm H.I.G. Capital, Ampac operates plants in California, Texas, and Virginia and is one of the largest U.S. producers of pharmaceutical chemicals. Its Virginia facility was once owned by the drugmaker Boehringer Ingelheim. SK has drug chemical operations in South Korea and last year acquired a Bristol-Myers Squibb plant in Ireland.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X